Vascular-Access Port Enlargement
by Norfolk Medical Products, Inc.
510(k) K841149
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK841149 | Date24 Apr 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LJT
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5965
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
This device is a subcutaneous, implanted vascular-access port designed for intravenous administration, blood sampling, and long-term venous access. It features an enlarged reservoir to accommodate higher fluid volumes, facilitating repeated or prolonged infusions while minimizing the need for frequent catheter replacements. The port is intended for use in general hospital settings, providing reliable access for chemotherapy, antibiotics, or parenteral nutrition in patients requiring chronic intravenous therapy.
The Vascular-Access Port Enlargement is supplied sterile and intended for single-use implantation by a healthcare professional. It is MRI-conditional under specific conditions, as defined by the manufacturer, and must be used with compatible catheters and connectors. The device is classified as Class II under FDA regulations and is available in various sizes to accommodate different patient needs. Storage requires adherence to sterile packaging guidelines, and proper surgical techniques are required for implantation and removal.
From the manufacturer
From the first human implant of a vascular access port (VAP) in 1982, to the first omni-directional access port in 1991, to the dynamic TidalPort™ of today, Norfolk Medical has pioneered innovative, cost-effective access solutions.
The NorPort Vascular Access Port family meets the needs of all patients, from small to large, boasts what we believe to be the most secure, reliable attachment mechanism in the field, and comes power rated and MRI-Conditional.
Other devices from Norfolk Medical Products, Inc.
Questions
AI-generated answers, 20 Sep 2026
What types of medical treatments is this vascular-access port specifically designed to support, and how does its enlarged reservoir benefit patients?
This device is designed for intravenous administration, blood sampling, and long-term venous access, particularly for patients requiring chronic therapy like chemotherapy, antibiotics, or parenteral nutrition. The enlarged reservoir accommodates higher fluid volumes, allowing for repeated or prolonged infusions without frequent catheter replacements, which reduces patient discomfort and procedural risks.
Is this port reusable, or is it intended for single-use only? How should it be stored to maintain sterility?
The device is explicitly intended for single-use implantation by a healthcare professional. To maintain sterility, it must be stored according to the sterile packaging guidelines provided by the manufacturer, ensuring the packaging remains unopened and undamaged until use.
Can this port be used in an MRI setting, and what precautions must be taken if so?
Yes, this port is MRI-conditional under specific conditions as defined by the manufacturer. However, it must only be used with compatible catheters and connectors, and MRI procedures must adhere to the manufacturer’s guidelines to avoid risks such as heating or displacement.
What sizes or models are available for this vascular-access port, and how do they accommodate different patient needs?
The device is available in various sizes to suit different patient anatomies and clinical requirements. While exact dimensions aren’t specified here, the design emphasizes flexibility for long-term venous access, ensuring compatibility with a range of patient profiles in general hospital settings.
What regulatory pathway was followed for this device’s approval, and what class does it fall under?
This device underwent a Traditional 510(k) review through the FDA’s General Hospital (HO) Advisory Committee, with a decision of Substantially Equivalent (SESE). It is classified as Class II under FDA regulations, indicating it poses moderate risk and requires special controls beyond general controls.